Dennis Whyte

Like, it advances science, which is an interesting synergy, right?

And it's the same thing that we think is going to happen in fusion, that namely, this is a bootstrap effect that actually, that when you start to push yourself to think about near-term commercialization, it allows the science to get in hand faster, which then allows the commercialization to go faster and up we go.

By the way, we've seen this also in another, again, you have to watch out with analogies because they only can go so far, but like biotech.

is another one.

Like, you look at the Human Genome Project, which was, it's sort of like, to me, that's like mapping the human genome is like that we can make net energy from fusion.

Like, it's one of those, like, in your drawer that you go, this is a significant achievement by humanity, right, in this century.

And there's the human genome project, fully government funded.

It's going to take 20, 25 years because we basically know the technology.

We're just going to be really diligent, keep going.

And then all of a sudden what comes along?

Disruptive technology, right?

You can sequence, you know, shotgun sequencing and computer, you know, recognition patterns.

And basically, oh, I can do this a hundred times faster, right?

Like, wow, right?

So that's really the, you know, to me, the story about why we started, why we launched Commonwealth Fusion Systems was more than just about another source of funding, which it is a different source of funding because it comes from, it's also a different purpose, which is very important.

It is.

Yeah.

And sometimes that brashness doesn't bear out.

You know, that's an aspect that you just take a different risk profile as well, too.

But you're right.